메뉴 건너뛰기
Neurology
Volumn 68, Issue 2, 2007, Pages 88-89
Enzyme replacement for infantile Pompe disease: The first step toward a cure
Author keywords

[No Author keywords available]
Indexed keywords

RECOMBINANT ENZYME; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; UNCLASSIFIED DRUG;
EID: 33846094491     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000253226.13795.40     Document Type: Editorial
Times cited : (14)
References (9)
  • 1
    • 33744951603 scopus 로고    scopus 로고
    • Emerging strategies for the treatment of hereditary metabolic storage disorders
    • Brady RO. Emerging strategies for the treatment of hereditary metabolic storage disorders. Rejuvenation Research 2006;9:237-244.
    • (2006) Rejuvenation Research , vol.9 , pp. 237-244
    • Brady, R.O.1
  • 2
    • 33645084802 scopus 로고    scopus 로고
    • Fabry disease
    • Levin M. Fabry disease. Drugs Today 2006;42:65-70.
    • (2006) Drugs Today , vol.42 , pp. 65-70
    • Levin, M.1
  • 3
    • 16844384688 scopus 로고    scopus 로고
    • Enzyme replacement therapy in mucopolysaccharidosis type I
    • Miebach E. Enzyme replacement therapy in mucopolysaccharidosis type I. Act Paediatr Suppl 2005;94:58-60.
    • (2005) Act Paediatr Suppl , vol.94 , pp. 58-60
    • Miebach, E.1
  • 4
    • 33747209013 scopus 로고    scopus 로고
    • A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
    • Muenzer J, Wraith JE, Beck M, et al. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006;8:465-473.
    • (2006) Genet Med , vol.8 , pp. 465-473
    • Muenzer, J.1    Wraith, J.E.2    Beck, M.3
  • 5
    • 33846033132 scopus 로고    scopus 로고
    • Recombinant human acid a-glucosidase: Major clinical benefits in infantile-onset Pompe disease
    • Kishnani PS, Corzo D, Nicolino M, et al. Recombinant human acid a-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2006;68:99-109.
    • (2006) Neurology , vol.68 , pp. 99-109
    • Kishnani, P.S.1    Corzo, D.2    Nicolino, M.3
  • 6
    • 33846079722 scopus 로고    scopus 로고
    • Broad spectrum of Pompe disease in patients with the same c.-32-13T>G haplotype
    • Kroos MA, Pomponio RJ, Hagemans ML, et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T>G haplotype. Neurology 2006;68:110-115.
    • (2006) Neurology , vol.68 , pp. 110-115
    • Kroos, M.A.1    Pomponio, R.J.2    Hagemans, M.L.3
  • 7
    • 33745684367 scopus 로고    scopus 로고
    • A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type I
    • Connock M, Juarez-Garcia A, Few E, et al. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type I. Health Technol Assess 2006;10:20.
    • (2006) Health Technol Assess , vol.10 , pp. 20
    • Connock, M.1    Juarez-Garcia, A.2    Few, E.3
  • 8
    • 33745696605 scopus 로고    scopus 로고
    • The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease; a systematic review
    • Connock M, Burls A, Frew E, et al. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease; a systematic review. Health Technol Assess 2006;10:24.
    • (2006) Health Technol Assess , vol.10 , pp. 24
    • Connock, M.1    Burls, A.2    Frew, E.3
  • 9
    • 0742270401 scopus 로고    scopus 로고
    • The artificial heart
    • Jauhar S. The artificial heart. N Engl J Med 2004;350:542-544.
    • (2004) N Engl J Med , vol.350 , pp. 542-544
    • Jauhar, S.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.